Genomic Characterization of Nine Clostridioides difficile Strains Isolated from Korean Patients Diagnosed With a CDI

Seung Woo Ahn # 1Se Hee Lee # 1Uh Jin Kim 2Hee-Chang Jang 2Hak-Jong Choi 1Hyon E Choy 3Seung Ji Kang 4Seong Woon Roh 5


Background: Clostridioides difficile infection (CDI) is an infectious nosocomial disease caused by Clostridioides difficile, an opportunistic pathogen that occurs in the intestine after extensive antibiotic regimens.

Results: Nine C. difficile strains (CBA7201-CBA7209) were isolated from nine patients diagnosed with CDI at the national university hospital in Korea, and the whole genomes of these strains were sequenced to identify their genomic characteristics. Comparative genomic analysis was performed using 51 reference strains and the nine isolated herein. Phylogenetic analysis based on 16S rRNA gene sequences confirmed that all 60 C. difficile strains belong to the genus Clostridioides, while core-genome tree indicated that they were divided into five groups, which was consistent with the results of MLST clade analysis. All strains were confirmed to have a clindamycin antibiotic resistance gene, but the other antibiotic resistance genes differ depending on the MLST clade. Interestingly, the six strains belonging to the sequence type 17 among the nine C. difficile strains isolated here exhibited unique genomic characteristics for PaLoc and CdtLoc, the two toxin gene loci identified in this study, and harbored similar antibiotic resistance genes.

Conclusion: In this study, we identified the specific genomic characteristics of Korean C. difficile strains, which could serve as basic information for CDI prevention and treatment in Korea.

Keywords: Antibiotic resistance gene; Clostridioides difficile; Clostridioides difficile infection; Comparative genomics; Pathogenic features; Toxin A and toxin B.

Conflict of interest statement

The authors declare that they have no competing interests.



    1. Chandrasekaran R, Lacy DB. The role of toxins in Clostridium difficile infection. FEMS Microbiol Rev. 2017;41(6):723–750. doi: 10.1093/femsre/fux048. – DOI – PMC – PubMed
    1. Lessa FC, Winston LG, McDonald LC. Emerging infections program CdST: burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(24):2369–2370. – PubMed
    1. van Dorp SM, Notermans DW, Alblas J, Gastmeier P, Mentula S, Nagy E, Spigaglia P, Ivanova K, Fitzpatrick F, Barbut F, et al. Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. Euro Surveill. 2016 doi: 10.2807/1560-7917.ES.2016.21.29.30292. – DOI – PubMed
    1. Borren NZ, Ghadermarzi S, Hutfless S, Ananthakrishnan AN. The emergence of Clostridium difficile infection in Asia: a systematic review and meta-analysis of incidence and impact. PLoS ONE. 2017;12(5):e0176797. doi: 10.1371/journal.pone.0176797. – DOI – PMC – PubMed
    1. Lee YJ, Choi MG, Lim CH, Jung WR, Cho HS, Sung HY, Nam KW, Chang JH, Cho YK, Park JM, et al. Change of Clostridium difficile colitis during recent 10 years in Korea. Korean J Gastroenterol. 2010;55(3):169–174. doi: 10.4166/kjg.2010.55.3.169. – DOI – PubMed

To view article in its entirety please click on the following link: